Objectives-To assess whether exercise induced suppression of heart rate variability in the low frequency domain (0.06-0-15 Hz) is related to the increase in circulating catecholamine concentrations.
Design-Randomised crossover trial of three exercise tests characterised by different workloads. Pharmacological simulation of exercise-induced changes in vagal and sympathetic activity. Participants-Six healthy men with a mean age of 31-2 (SD 3.0) years. Interventions-Three different workloads of steady state cycling ergometry: control state without cycling, cycling at a target heart rate of 100 beatslmin, and cycling at a target heart rate of 150 beatsimin. Intravenous infusion of atropine (target heart rate 100 beats/min) followed by the additional infusion of adrenaline and noradrenaline. Main outcome measures-Fast Fourier analysis of heart rate variability; blood pressure; and venous plasma concentrations of lactate, adrenaline, and noradrenaline.
Results-During the control exercise period there were no changes in the assessed variables compared with the preceding resting period. During exercise at a heart rate of 100 beats/min systolic blood pressure increased and heart rate variability decreased. During exercise at a heart rate of 150 beats/min systolic blood pressure and lactate, adrenaline, and noradrenaline concentrations increased. In addition, low frequency (LF) was lower than during exercise at 100 beats/min, high frequency (HF 0-15-0*80 Hz) resembled that during exercise at 100 beats/min, and diastolic blood pressure was reduced. Infusion of atropine caused no changes in blood pressure or plasma concentrations of lactate, adrenaline, and noradrenaline and decreased heart rate variability. The additional infusion of adrenaline and noradrenaline completely suppressed heart rate variability and increased blood pressure Conclusions-The reduction in LF and HF during exercise at a heart rate of 100 beatsimin, which is not characterised by increased plasma catecholamine concentrations, and during atropine infusion suggests that heart rate variability in the supine state is largely influenced by vagal activity. The additional reduction in LF during exercise at 150 beats/min and during catecholamine infusion may reflect a negative feedback of circulating catecholamines on the sympathetic control of heart rate. (Br HeartJ 1993; 70:144-149) The assessment of heart rate variability has been proposed as a new tool in cardiovascular research.'-3 The interest in this method is based on the assumption that the analysis of heart rate variability provides a non-invasive insight into the autonomic regulation of the heart. Therefore heart rate variability is also regarded as a predictor of arrhythmic events in patients after infarction. 4 Studies in humans7-9 as well as in animals'01' have shown relations between sympathetic and parasympathetic activity and the different spectral components of heart rate variability. The power spectral density of the low frequency band (LF) is thought to reflect solely sympathetic activity7 12 or to be an index of both vagal and sympathetic activity.89'3 Heart rate variability in the high frequency band (HF) is attributed to vagal activity.2814 The ratio of LF to HF has been suggested to reflect the sympathovagal balance3 or to be an indicator of sympathetic nervous activity. '5 Attempts have been made to expand the diagnostic use of exercise tests by the additional consideration of heart rate variability.15-'7 These studies unanimously showed a decrease in heart rate variability during exercise. The well established sympathetic activation which is indicated by an increase in plasma catecholamine concentrations"'20 was thus not reflected in an increase in LF power in these studies, as would be anticipated from the association of LF power to sympathetic activity.
The present study was performed to assess the relation between the exercise induced suppression of LF variability and the increase in plasma catecholamine concentrations. We therefore simultaneously measured heart rate variability and plasma catecholamine concentrations during steady state Heart rate variability and plasma adrenaline, noradrenaline and lactate concentrations were determined in three sequential intervals of 256 s during the following 13 minutes of rest. Blood pressure was measured with a sphygmomanometer and standard cuff at the end of the rest period.
An exercise period of eight minutes then followed. In the control state the subject had his feet on the pedals but did not cycle. In another period he cycled to achieve a steady state heart rate of 100 beats/min from the third to the eighth minute, and in another he cycled to achieve a steady state heart rate of 150 beats/min from the third to the eighth minute. The target heart rate was reached in the first three minutes by increasing the workload. At the end of the eighth minute blood was sampled for determination of plasma adrenaline, noradrenaline, and lactate concentrations. Blood pressure was measured immediately at the end of the exercise.
PHARMACOLOGICAL PROTOCOL
As in the exercise protocol the volunteers lay relaxed with their feet resting on the pedals of the ergometer. One cannula was inserted into the right antecubital vein for blood sampling and another was inserted into the left antecubital vein for the continuous infusion of atropine (Atropinsulfat Braun; Braun Melsungen, Melsungen, Germany) and catecholamines (Suprarenin and Arterenol; Hoechst, Frankfurt, Germany). The ratio of noradrenaline to adrenaline concentration for each subject was the same as that previously measured at the eighth minute of exercise with a target heart rate of 150 beats/min. The catecholamines were diluted in 50 ml physiological saline and infused with an electrical infusion pump (Perfusor ED 2; Braun Melsungen, Melsungen, Germany). Blood pressure was recorded every two minutes by an automatic sphygmomanometer (Tonoprint; Speidel and Keller, Jungingen, Germany). After an adaptation period of 20 minutes heart rate variability was determined during the subsequent 13 minutes of rest. Then atropine was infused at a dose sufficient to increase heart rate to 100 beats/min within five minutes with an initial bolus injection (1 mg) and a subsequent continuous infusion (34 (13) ,ug/min). Heart rate variability was determined over five minutes at a steady state heart rate of 100 beats/min. The catecholamine infusion was then added while the atropine infusion was continued. The infusion rate was increased until the diastolic blood pressure had increased by 30 mm Hg or had reached 120 mm Hg or the systolic blood pressure had increased by 70 mm Hg or had reached 200 mm Hg. The infusion rate (adrenaline 2-3 (1.4) ,ug/min, noradrenaline 14-9 (3'7) 4ug/min) was then kept constant for an additional five minutes and heart rate variability assessed. Blood samples were drawn at rest, during the infusion of atropine just before the start of the infusion of catecholamines, and immediately before stopping the infusion of atropine and catecholamines. DATA Heart rate variability and plasma adrenaline, noradrenaline and lactate concentrations were not different during the three sequential resting periods and were therefore averaged. There were also no differences between the different resting periods preceding the three exercise protocols.
During control state without cycling all variables remained unchanged. During the two other exercise protocols heart rate increased from 69 (9) to 101 (4) beats/min and from 70 (8) to 157 (5) beats/min. Systolic blood pressure increased from 118 (9) to 130 (9) mm Hg during exercise with a heart rate of 100 beats/min and from 120 (7) to 169 (21) mm Hg during exercise with a heart rate of 150 beats/min. Diastolic blood pressure was not changed during exercise at 100 beats/min and decreased from 78 (5) to 65 (4) mm Hg during exercise at 150 beats/min. LF and HF decreased from rest to exercise during both exercise protocols targeted at increasing heart rate ( fig 1) . LF was lowest during the most streneous exercise protocol. The LF to HF ratio decreased from rest to exercise at 150 beats/min (table) . Plasma adrenaline, noradrenaline, and lactate concentrations increased from rest to exercise at 150 beats/min (fig 2) .
The variables measured during the resting period of the pharmacological protocol did not differ from those measured during the resting periods of the exercise protocol. During the infusion of atropine heart rate increased from 67 (6) to 95 (10) beats/min. Blood pressure remained constant. LF and HF decreased considerably (fig 1) .
During the additional infusion of nor- group.bmj.com on April 3, 2017 -Published by http://heart.bmj.com/ Downloaded from Heart rate, systolic and diastolic blood pressures, LF to HF ratio and plasma lactate concentrations during exercise and pharmacological protocols. Values are means (SD) (7) 78 (5) 2-4 (1-0) 0-82 (0-13) Heart rate 150 beats/min 157 (5) 169 ( adrenaline and adrenaline heart rate increased further to 123 (6) beats/min. Systolic blood pressure increased from 118 (4) to 186 (16) mm Hg and diastolic blood pressure from 83 (5) to 105 (7) mm Hg. The remaining heart rate variability was completely suppressed (fig 1) . In four volunteers plasma lactate concentration increased from 0 79 (0 22) to 1-21 (0 38) mmol/l during the catecholamine infusion. In these volunteers the infusion rate of adrenaline (2-9 (1 3) pg/min) was higher than in those volunteers who had no increase in plasma lactate concentrations (1a 1 (0 8) pg/min).
Discussion
Our results confirm the well known decrease in heart rate variability induced by exercise.161725 Humoral factors such as circulating catecholamines may thus have a more dominant role than direct neural input in sustaining the tachycardia during steady state exercise.26 To study the impact of circulating catecholamines on heart rate variability we therefore measured simultaneously heart rate variability and plasma catecholamine concentrations during different exercise intensities as well as the effect of intravenously infused atropine and catecholamines.
To achieve comparable conditions for all volunteers the workload was adjusted individually with respect to the exercise induced heart rate response. During the pharmacological protocol we intended to achieve the same heart rates as in the exercise protocol with a heart rate of 150 beats/min. Yet the pressor action of the infused catecholamines limited the maximal infusion rate. Thus, the maximal achieved heart rate during the infusion of catecholamines remained lower than during exercise at a heart rate of 150 beats/min.
As the tachycardia induced by dynamic exercise is mediated both by an initial rapid vagal withdrawal and by a more delayed increase in sympathetic activity at higher levels of workload,27 8 we simulated the vagal withdrawal with atropine before then starting the infusion of catecholamines.
Nevertheless, there were considerable differences between the two experimental procedures (exercise v infusion of atropine and catecholamines). The plasma concentrations of the infused catecholamines necessary to induce the observed haemodynamic changes were higher than those measured during exercise at a heart rate of 150 beats/min, although heart rate remained lower. This discrepancy, previously reported by others,192930 may be because most of the endogenously released noradrenaline does not reach the circulating blood because of its early inactivation by reuptake into sympathetic nerve terminals. 31 Our approach of using an individually calculated ratio of noradrenaline to adrenaline concentrations seems to be more appropriate than a fixed arbitrary ratio for all volunteers. Nevertheless, it remains unclear whether a ratio of noradrenaline to adrenaline calculated from venous blood sampled in an antecubital vein reliably reflects what is happening in the affected organs.'2 The determination of the catecholamine spillover in the coronary sinus effluent will certainly more closely reflect changes in the activity of cardiac sympathetic nerves. Yet, the present approach is 0-070 . 33 The calculation of heart rate variability power spectra by autoregressive techniques may improve the spectral resolution but requires predetermination of the autoregressive order of the analysed system.34 The following parametric decomposition of a given data set and the calculation of the power spectrum assumes that the selected autoregressive order adequately describes the system under study. This autoregressive order may, however, vary between different subjects and even within a single subject under different physiological conditions. Therefore we calculated the power spectra by fast Fourier transformation because this method is free from any assumptions about the system under study. Despite these methodological differences there is nevertheless a close correlation between heart rate variability indices derived from fast Fourier transformation algorithms and autoregressive methods.35 In principle, heart rate variability can be quantified in absolute values or fractional values normalised to total power. Because of the considerable reduction in total power during exercise17 small changes in the absolute values of one spectral band can considerably influence the fractional values in all other frequency bands. That is why we studied absolute heart rate variability values.
Our data showing a profound suppression of LF during exercise do not support the concept that LF reflects solely sympathetic activity,7 12 but they do agree with data indicating that LF is influenced by both vagal and sympathetic activity.8 9 13 Our data also do not support the assumption that the LF to HF ratio may serve as an index of sympathetic activity when exercise intensity exceeds the ventilatory threshold.'5 The venous lactate concentration during exercise at 150 beats/min clearly indicates that the ventilatory threshold was indeed exceeded but the LF to HF ratio was nevertheless decreased.'6 The observed increase in lactate concentration during catecholamine infusion in some volunteers has been previously reported3738 and is explained by the fact that the adrenaline induced decrease in tissue oxygenation of some organs is sufficient to impair normal carbohydrate metabolism so that excess lactate is formed. '8 Beat by beat modulation of atrioventricular conduction by vagal or sympathetic activity, or both, may contribute to the analysed RR variability. In conscious dogs the oscillations in atrioventricular conduction are predominantly dependent on changes in vagal activity and can be blocked by atropine. Yet, changes in atrioventricular conduction contribute no more than 3% to changes in the RR interval.3940
The considerable reduction in heart rate variability during exercise at a heart rate of 100 beats/min as well as during atropine infusion point to a major impact of vagal activity on both LF and HF. The additional reduction in LF during exercise at a heart rate of 150 beats/min and of all heart rate variability indices during infusion of catecholamines can be explained by an additional negative feed back of the circulating catecholamines on sympathetic heart rate control. Likewise, a negative relation between spectral and nonspectral measurements of heart rate variability and plasma noradrenaline concentration was recently reported in patients with congestive heart failure.41 High plasma noradrenaline concentrations were accompanied by low values of heart rate variability.
The observed reduction in heart rate variability during exercise as well as during the infusion of atropine and catecholamines questions the use of heart rate variability measurements as a tool to differentiate between sympathetic and vagal activity during exercise.
